|
B3GALTL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.574800E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.127840E-02 |
| Normal-vs-Stage2 |
2.906300E-02 |
| Normal-vs-Stage3 |
2.08089999998995E-05 |
| Normal-vs-Stage4 |
7.798300E-03 |
| Stage1-vs-Stage2 |
8.979400E-01 |
| Stage1-vs-Stage3 |
4.339800E-02 |
| Stage1-vs-Stage4 |
5.330200E-01 |
| Stage2-vs-Stage3 |
1.970590E-01 |
| Stage2-vs-Stage4 |
7.182400E-01 |
| Stage3-vs-Stage4 |
4.074600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.9626999999951E-05 |
| Normal-vs-AfricanAmerican |
5.653800E-01 |
| Normal-vs-Asian |
2.694400E-01 |
| Caucasian-vs-AfricanAmerican |
2.248400E-01 |
| Caucasian-vs-Asian |
8.138400E-01 |
| AfricanAmerican-vs-Asian |
4.563400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.699430E-03 |
| Normal-vs-Female |
1.758030E-03 |
| Male-vs-Female |
5.644000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.455900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.249910E-02 |
| Normal-vs-Age(61-80Yrs) |
9.61019999999868E-05 |
| Normal-vs-Age(81-100Yrs) |
5.256800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.484400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.886600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.514000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.465600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.143380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.641800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.235800E-01 |
| Normal-vs-Grade 2 |
1.433730E-02 |
| Normal-vs-Grade 3 |
1.999180E-03 |
| Normal-vs-Grade 4 |
1.51013999999394E-05 |
| Grade 1-vs-Grade 2 |
1.362590E-01 |
| Grade 1-vs-Grade 3 |
8.751600E-02 |
| Grade 1-vs-Grade 4 |
5.520600E-03 |
| Grade 2-vs-Grade 3 |
9.162000E-02 |
| Grade 2-vs-Grade 4 |
4.248000E-04 |
| Grade 3-vs-Grade 4 |
7.432000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.551500E-02 |
| Normal-vs-ccB subtype |
1.037380E-04 |
| ccA subtype-vs-ccB subtype |
4.419500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.243200E-03 |
| Normal-vs-N1 |
3.803900E-04 |
| N0-vs-N1 |
1.483640E-02 |
|
|
